A Cure for Diabetes? Groundbreaking Trial Ends Need for Insulin Injections and Immune Drugs

- A Functional Cure: A revolutionary cell therapy has allowed a type 1 diabetes patient's body to produce its own insulin again, six months after a single treatment.
- No More Immune Suppression: For the first time, engineered "stealth" islet cells have survived and functioned without the need for lifelong, high-risk immunosuppressant drugs.
- The End of a Century-Long Struggle: This breakthrough marks a potential paradigm shift, moving beyond managing diabetes to actually curing it, freeing patients from the daily burden of injections and monitoring.
For over a century, the nine million people living with type 1 diabetes have been locked in a relentless battle, dependent on daily insulin injections to survive. Now, a stunning breakthrough from Sana Biotechnology1 and Uppsala University Hospital may finally signal the end of that fight.
In a landmark first-in-human trial, a patient with type 1 diabetes received a one-time transplant of uniquely engineered pancreatic islet cells. These cells, modified with Sana’s "hypoimmune" (HIP) technology, act like they have an invisibility cloak, hiding them from the body's own immune system which would normally destroy them2, 4.
The results after six months are nothing short of revolutionary. The patient’s body is producing its own insulin, with levels rising naturally after a meal—a function lost to those with the disease7. Most critically, this was achieved without any immunosuppressant drugs, a holy grail in transplant medicine that avoids severe side effects6. PET-MRI scans confirmed the "stealth" cells are alive and well, working silently in the patient's forearm muscle.
"We believe today’s six-month update continues to suggest that a functional cure for type 1 diabetes without immunosuppression is possible,” stated Dr. Per-Ola Carlsson, the study's principal investigator2.
This successful trial validates a new frontier in medicine. Sana is already developing the next generation of this therapy using stem cells, aiming to create an unlimited supply of these life-changing cells5. For the first time in 100 years, a world without the daily burden of type 1 diabetes is not just a dream—it's becoming a clinical reality.
References
Stay Updated!
Get the latest biotech and pharma news delivered to your inbox.